SGHTSight Sciences, Inc.

$8.97+75% 1Y

Is the price fair?

What SGHT's price assumes

Sight Sciences, Inc. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 3.54× revenue.

3.54

Price / sales · no P/E: the last twelve months did not end in a profit

Price / book
5.57

Price / book · as of 2026-Q2

EV / sales
3.19

EV / sales

Details›
Price / bookas of 2026-Q2
5.57
EV / EBIToperating margin −33%: the multiple describes the denominator
not meaningful
EV / salesas of 2026-Q2
3.19
Market capitalisation55.1 million shares, counted Jul 31, 2026
$494M

Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.